R&D Center

R&D Center

副标题

We focus ondiscovering, developing and delivering drugs in therapeutic areas where we haveproven expertise and where we can have an impact. These areas include:

● GastrointestinalSystem

CNS

Otorhinolaryngology

And we are going toexpand our areas to:

Oncology

Endocrineand metabolism

Immunology

Cardiac-cerebralvascular disease



Pharscin Pharma places R&D and innovation higher on its agenda and has established a pharmaceutical research institute in ways that guarantee the successful implementation of research plans. Its R&D covers the research and development of TCM cultivation, extraction, classic prescription and preparations. In addition, it is also responsible for the research and development of chemical-drug  product lines of APIsand their preparations. These products cover therapeutic fields as varied as digestive system, neuropsychiatric system, ENT, Oncology, endocrine and metabolism regulation, cardiovascular and cerebrovascular systems. After years of operation, the company possesses strong technical industrialization transformation ability and is well capable of understanding Chinese laws and regulations on drug administrationand following theses regulations in everything it does. On top of that, the company has strong ability of drug registration and application that allows the company to quickly register domestic and foreign products. The company has built active partnerships with domestic and foreign companies in ways that jointly carry out research and development work in fields as varied as drug discovery and development, manufacturing process development, intelligent manufacturing, and drug clinical research. By doing so, the company is well-poised to embrace new opportunities and challenges brought about by the changes in the global pharmaceutical industry.

Research Team

Research Team

副标题

Pharscin Pharma Institute has research stationsfor academicians and post doctorates, with the coverage of 4,000 square metersand a total investment of nearly 100 million yuan.Ithas departments of TCM study, chemical APIs synthesis, finished pharmaceutical products,analytical quality, clinical study, information center and other departments.Each R&D professional platform has R&D labs and small and medium-scaletrial production workshops, realizing smooth transitionfrom new products andnew processes to industrialization.At the same time, Pharscin Pharma is equippedwith the Intellectual Property Department, the Drug Regulatory AffairsDepartment,and R&D Quality Management Department.Theinstitute now has nearly 100 researchers, including 5 Doctors and more than 20senior technical professionals.


The Pharmaceutical Research Institute has modernand advanced research and development facilities, including process researchequipment like CO2 supercritical extraction, fluidized bed coatingequipment for pellets, dry/wet high efficiency granulator, spray dryer, jetmill, capsule filling machine, rotary tabletingmachine, freeze dryer. In addition, it also hasanalytical testing equipment as varied as ultra high performance liquidchromatography, gas chromatography, GC-MS, atomic absorption spectrometer,laser particle size analyzer, moisture adsorption analyzer and thin layerscanner.Since its establishment,the company has successfully completed the industrialization research of aseries of new drugs. It is the "National Modern Engineering TechnologyPlatform for Chinese Medicine" and "Chongqing Municipal ModernEngineering and Research Center for Traditional Chinese Medicine" and"Chongqing Engineering Research Center for Traditional Chinese MedicineExtraction and Separation Technology"

R&D Achievements

R&D Achievements

副标题

The company has yield notable achievements inR&D.For more than a decade, the company has remainedcommitted to the combination of Chinese and Western technologies, and has paidcloser attention to the fields of digestive system, the neuropsychiatric systemand theotolaryngology. The company is now expanding its pipeline into fields as variedas cardio-cerebralvascular diseases, metabolic chronic diseases and oncology.Sinceits establishment, the company which startedwith one health care product approval has gradually obtained the first generic drug approvals  such as Weidimei ( HydrotalciteTablets /Chewable tablets), Changsong (Macrogol 4000Powder),Gabexate Mesylate for Injection and unique Chinese patent medicines likeDuliang Soft Capsules, Tongxiening Granules, Ganjuebingmei Tablets, Liuweianshen Capsules, and BaweiqilongGranules.Currently, it has 68 drugapprovals, including 49 drugs in the national "medical insurance"catalog, 46 drugs with domestic patents and one with the international patent.The R&D and project application team of thecompany has successively undertaken the high-tech industrialization project ofthe national development and reform commission, the "Twelfth Five-YearPlan" major new drug innovation projects of the Ministry of Science andTechnology, and research projects of the State Administration of TCM of the TCMindustry andnearly 100 scientific research projects ofChongqing Municipality.The company obtained two" National Patent Award" and one"Third Prize ofNational Prize for Progress in Science and Technology".

R&D Honor

R&D Honor

副标题

Enterprise Honor

Date

Awarders

Name of Honors

December 2018

Chongqing Economic and Information Technology Commission, Chongqing Human  Resources and Social Security Bureau, Chongqing Science and Technology  Commission, Communist Youth League Chongqing Municipal Committee, Chongqing  Guidance Bureau for the Development of Small and Medium Sized Enterprises,  Chongqing Municipal Intellectual Property Office

Top 100 Innovative Enterprises in Chongqing

February of 2018

Chongqing Economic and Information Technology Commission

Outstanding Technology Innovation Demonstration Enterprise

July of 2017

Chongqing Municipal People's Government

Chongqing Enterprise Technology Innovation Award

March 2017

Chongqing Municipal People's Government

The 6th Chongqing Mayor Quality Award

December 2017

State Intellectual Property Office of the People's Republic of China

National Intellectual Property Demonstration Enterprise

September 2016

The Organizing Committee of China Pharmaceutical R&D Innovation  Association, WWW.Yaozh.Com, China Pharmacy Magazine

2016 China's top 50 R&D Companies of TCM, 2016 China's Top 50 Drug  R&D Companies

December 2015

State Intellectual Property Office of the People's Republic of China

National Intellectual Property Advantage Enterprise

January 2015

Chongqing Economic and Information Technology Commission

2014 Demonstration Enterprise of Technological Innovation

November 2014

Torch High-tech Industry Development  Center of Ministry of Science and Technology

Key High-Tech Enterprise of the National Torch Program

April 2012

State Administration for Industry and Commerce of the People's Republic of  China

"Pharscin Pharma" trademark was named as the "Well-Known  Trademark"

March 2011

Chongqing Development and Reform Commission, Chongqing Economic and  Information Commission, Chongqing Science and Technology Commission

The Champion in the National High-Tech Industrial Base

December 2010

Torch High-tech Industry Development  Center of Ministry of Science and Technology

Key High-Tech Enterprise of the National Torch Program

December of 2008

National Science and Technology

National High-Tech Enterprise

October 2004

Chongqing Administration for Industry and Commerce

"Pharscin Pharma" trademark was named as the "Chongqing  Well-Known Trademark"

December of 1998

Chongqing Science and Technology Commission

High-tech enterprise



Honors for Products

Time

Awarders

Name of Honors

July 2018

Chongqing Municipal People's Government

Tongxiening Granules was awarded the "Third Prize of National Prize for Progress in Science and Technology".

December 2017

State Intellectual Property Office of the People's Republic of China

Duliang Soft Capsule won the "China Patent Excellence Award"

December 2016

State Intellectual Property Office of the People's Republic of China

Weidimei (Hydrotalcite Tablets )won the "China Patent Excellence Award"

December 2016

China Federation of Industry and Commerce

Duliang Soft Capsule was awarded the "Third Prize of National Prize for  Progress in Science and Technology"

January 2016

China Food and Drug Administration

Ganju Binmei Tablets was listed as "National Second Class Traditional Chinese Medicine Protection Variety"

October 2014

China Science and Technology Ministry

Tongxiening Granules won the "National Torch Program Project Certificate"

In September 2014

Chongqing Municipal People's Government

Duliang Soft Capsule won "The Third Prize of Science and Technology  Progress"

August 2013

China Food and Drug Administration

Duliang Soft Capsule was listed as "National Second Class Traditional  Chinese Medicine Protection Variety"

January 2013

Chongqing Municipal People's Government

Duliang Soft Capsule won " the Second Prize of 2011-2012 Chongqing  Excellent New Product"

December 2009

Chongqing Municipal People's Government

Weidimei (Hydrotalcite Tablets ) won the Third Prize of 2009 Chongqing Science and Technology

November 2008

China Science and Technology Ministry

Duliang Soft Capsule won the "National Torch Program Project  Certificate"

December 2007

Chongqing Municipal People's Government

Weidimei (Hydrotalcite Tablets ) and Shuiwang Spirulina Capsules are Famous Brand Products of Chongqing

September 2006

China Food and Drug Administration

Spirulina Capsule was listed as the National Second Class Traditional Chinese  Medicine Protection Variety"

April 2006

China Food and Drug Administration

Duliang Soft Capsule was listed as "National Second Class Traditional  Chinese Medicine Protection Variety"

May 2000

Chongqing Municipal People's Government

Shuiwang (Spirulina Capsule) won "The Third Prize for Excellent New  Products in 1998"

July 1999

China Food and Drug Administration

Spirulina Capsule was listed as “National Second-Class Chinese Medicine  Protection Variety”